Although the revenue and EPS for UiPath (PATH) give a sense of how its business performed in the quarter ended July 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
UiPath and BlackSky Technology showcase contrasting growth stories, from automation gains to satellite-driven intelligence.
In the latest trading session, UiPath (PATH) closed at $11.17, marking a +2.57% move from the previous day.
PATH powers growth with its AI-driven automation platform, posting rising revenues, strong adoption and a major buyback plan.
UiPath stock slides 11% in three months, but strong automation demand, key tech partnerships and solid finances keep it in focus.
UiPath's alliances with tech giants, rising revenues, and strong customer retention fuel its edge in the fast-growing automation market.
UiPath (PATH) reached $10.73 at the closing of the latest trading day, reflecting a -2.37% change compared to its last close.
UiPath (PATH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The latest trading day saw UiPath (PATH) settling at $10.93, representing a -2.58% change from its previous close.
UiPath (PATH) reached $11.77 at the closing of the latest trading day, reflecting a -2.04% change compared to its last close.
There is no denying that PATH has missed the first train for Agentic AI monetization, as observed in the decelerating growth hinted by the management's FY2026 guidance. With competition also heating up, it remains to be seen if PATH may report a renewed H2'25 growth opportunity through the recently released Agentic Automation in April 2025. On the other hand, PATH's market leadership in the RPA market remains compelling, significantly aided by the growing ARR and the rich cash flows.
I recommend rotating into catalyst-driven small- and mid-cap stocks like UiPath to protect capital as the S&P 500 hits new highs. UiPath stands out with improving sales momentum, profitability, and a raised full-year outlook, making it a compelling buy despite recent volatility. The company is also growing FCF at a double-digit pace while trading at a very modest ~12x forward FCF.